0001415889-24-006005.txt : 20240229
0001415889-24-006005.hdr.sgml : 20240229
20240229211517
ACCESSION NUMBER: 0001415889-24-006005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240227
FILED AS OF DATE: 20240229
DATE AS OF CHANGE: 20240229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RABINOWITZ DANIEL
CENTRAL INDEX KEY: 0001857843
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 24706564
MAIL ADDRESS:
STREET 1: C/O NATERA, INC.
STREET 2: 13011 MCCALLEN PASS BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
4
1
form4-02292024_090201.xml
X0508
4
2024-02-27
0001604821
Natera, Inc.
NTRA
0001857843
RABINOWITZ DANIEL
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
AUSTIN
TX
78753
false
true
false
false
SEC. AND CHIEF LEGAL OFFICER
1
Common Stock
2024-02-27
4
M
0
27500
10.41
A
231718
D
Common Stock
2024-02-27
4
M
0
7807
9.29
A
239525
D
Common Stock
2024-02-27
4
S
0
35307
75.0927
D
204218
D
Common Stock
2024-02-29
4
M
0
20526
9.29
A
224744
D
Common Stock
2024-02-29
4
S
0
100
85.10
D
224644
D
Common Stock
2024-02-29
4
S
0
2600
86.6708
D
222044
D
Common Stock
2024-02-29
4
S
0
3400
87.8721
D
218644
D
Common Stock
2024-02-29
4
S
0
14426
89.7235
D
204218
D
Stock Option (right to buy)
10.41
2024-02-27
4
M
0
27500
0
D
2027-06-08
Common Stock
27500
0
D
Stock Option (right to buy)
9.29
2024-02-27
4
M
0
7807
0
D
2028-03-08
Common Stock
7807
20526
D
Stock Option (right to buy)
9.29
2024-02-29
4
M
0
20526
0
D
2028-03-08
Common Stock
20526
0
D
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.43 to $87.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.80 to $88.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.53 to $89.78 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option shares are fully exercisable.
/s/ Tami Chen, Attorney-in-Fact
2024-02-29